IMAGE: Diabetes Technology & Therapeutics is a monthly peer-reviewed journal that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. view New Rochelle, NY, October 11, 2018--In follow-up to the I HART CGM study, which showed the benefit of real-time continuous glucose monitoring compared to flash monitoring for time spent in hypoglycemia among adults with type 1 diabetes at high hypoglycemia risk, researchers conducted an extension trial that assessed the effects of continuing RT-CGM or switching from flash to RT-CGM of the subsequent 8 weeks.
IMAGE: Genetic Testing and Molecular Biomarkers reports on all aspects of genetic testing, including molecular and biochemical based tests and varied clinical situations; ethical, legal, social, and economic aspects of genetic... view New Rochelle, NY, Dec. 5, 2017-A new study assessed the effects of a SLC6A15 gene variant on resting-state brain function in patients with major depressive disorder , comparing the results with those in healthy individuals.
... have considerably better odds of receiving annual preventive care pediatrician visits, according to ... New Rochelle, NY, October 26, 2017-A new study has shown that low-income U.S. residents living in Medicaid expansion states are significantly ...
... support in the area and the recovery of skin volume and firmness," adds Patricia Ceballos, a dermatologist in New Rochelle, New York. "If dark, puffy [bags under your eyes] seem to be the morning problem, consider sleeping on your back with an extra ...
IMAGE: Genetic Testing and Molecular Biomarkers reports on all aspects of genetic testing, including molecular and biochemical based tests and varied clinical situations; ethical, legal, social, and economic aspects of genetic... view New Rochelle, NY, September 27, 2017-Pharmaceutical companies developing Orphan Drugs are increasingly partnering with direct-to-consumer genetic testing firms to identify individuals with rare diseases, in a trend that is raising concerns related to privacy, drug costs, and rising healthcare-related financial burden for consumers.
